Latest filing published 22 Sept 2009 for Accelerate Diagnostics, Inc, €4,512.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Charles E. Gerretson: trading record in brief
Charles E. Gerretson discloses dealings in Accelerate Diagnostics, Inc to SEC (Form 4). The record holds 7 filings, for trades running from 6 February 2009 to 18 September 2009.
Both buying and selling appear: 5 purchases worth €7,994, against 2 sales worth €6,714. Netting one side against the other leaves €1,280 of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The median purchase comes to €1,462.
Most recently, on 22 September 2009, the filings show an open-market sale worth €4,512 in Accelerate Diagnostics, Inc. The most recent open-market purchase was published on 19 February 2009, 6,472 days ago. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Charles E. Gerretson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$3.32Common StockSEC:0001050502-09-000232:0
- 1,000 shares@ US$3.24Common StockSEC:0001050502-09-000232:1
- 1,304 shares@ US$2.10Common StockSEC:0001050502-09-000057:0Canonical exit: 14 May 2009 (T+90)
- 300 shares@ US$2.02Common StockSEC:0001000096-09-000044:0Canonical exit: 10 May 2009 (T+90)
- 500 shares@ US$2.10Common StockSEC:0001000096-09-000044:1Canonical exit: 10 May 2009 (T+90)
- 896 shares@ US$2.10Common StockSEC:0001000096-09-000044:2Canonical exit: 12 May 2009 (T+90)
- 2,000 shares@ US$2.02Common StockSEC:0001000096-09-000042:0Canonical exit: 7 May 2009 (T+90)
7 of 7 declarations
